Table 4.
Univariate and multivariate logistic regression analysis for factors to predict impaired g-CFR (g-CFR < 2.0).
| Univariable analysis | Multivariable analysis 1 | Multivariable analysis 2 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | |
| Age, year | 1.004 | 0.967–1.043 | 0.83 | ||||||
| Male | 2.078 | 0.908–4.753 | 0.083 | ||||||
| HDL-chol, mg/dl | 0.979 | 0.946–1.013 | 0.21 | ||||||
| Creatinine, mg/dl | 11.182 | 1.190–105.102 | 0.035 | 10.614 | 1.036–108.771 | 0.047 | 9.903 | 1.375–127.6 | 0.047 |
| cTnI at presentation, ng/l | 1.011 | 0.986–1.036 | 0.39 | ||||||
| log (NT-proBNP), pg/ml | 1.270 | 0.942–1.712 | 0.12 | ||||||
| CRP, mg/dl | 0.769 | 0.358–1.651 | 0.50 | ||||||
| FFR | 0.627 | 0.040–9.910 | 0.74 | ||||||
| FFR ≤ 0.75 | 1.322 | 0.635–2.751 | 0.46 | ||||||
| Whole LV mass volume, g | 1.015 | 1.004–1.026 | 0.006 | ||||||
| LV mass index by CT, g/m2 | 1.030 | 1.009–1.051 | 0.004 | 1.018 | 0.995–1.042 | 0.052 | 1.007 | 0.987–1.029 | 0.070 |
| Area at risk mass volume, g | 1.012 | 0.9955–1.030 | 0.16 | ||||||
| Mean PCATA | 1.140 | 1.060–1.225 | < 0.001 | Not selected | 1.141 | 1.060–1.229 | 0.002 | ||
| Highest PCATA | 1.116 | 1.049–1.188 | 0.001 | Not selected | Not selected | ||||
| Target vessel PCATA | 1.096 | 1.034–1.161 | 0.002 | 1.095 | 1.032–1.161 | 0.003 | Not selected | ||
| EDV, ml | 1.020 | 1.004–1.036 | 0.016 | 1.011 | 0.993–1.029 | 0.10 | 1.011 | 0.994–1.030 | 0.19 |